Wave Life Sciences (WVE) Accounts Payables: 2015-2025
Historic Accounts Payables for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $14.5 million.
- Wave Life Sciences' Accounts Payables rose 13.37% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 13.37%. This contributed to the annual value of $16.3 million for FY2024, which is 26.66% up from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Accounts Payables is $14.5 million, which was down 1.19% from $14.7 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Accounts Payables peaked at $18.1 million during Q2 2024, and registered a low of $7.3 million during Q4 2021.
- Its 3-year average for Accounts Payables is $13.8 million, with a median of $12.8 million in 2023.
- Its Accounts Payables has fluctuated over the past 5 years, first slumped by 47.22% in 2021, then spiked by 132.32% in 2022.
- Quarterly analysis of 5 years shows Wave Life Sciences' Accounts Payables stood at $7.3 million in 2021, then soared by 132.32% to $16.9 million in 2022, then declined by 24.10% to $12.8 million in 2023, then increased by 26.66% to $16.3 million in 2024, then increased by 13.37% to $14.5 million in 2025.
- Its Accounts Payables stands at $14.5 million for Q3 2025, versus $14.7 million for Q2 2025 and $14.4 million for Q1 2025.